BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 7914349)

  • 1. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
    Kosugi S; Kohn LD; Akamizu T; Mori T
    Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intracellular region adjacent to plasma membrane (residues 684-692) of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
    Kosugi S; Mori T
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1497-503. PubMed ID: 8147896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    J Biol Chem; 1992 Dec; 267(34):24153-6. PubMed ID: 1332945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first cytoplasmic loop of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
    Kosugi S; Mori T
    FEBS Lett; 1994 Mar; 341(2-3):162-6. PubMed ID: 8137933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
    Kosugi S; Ban T; Kohn LD
    Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
    Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Signal transduction of the thyrotropin receptor].
    Kosugi S; Mori T
    Nihon Rinsho; 1994 Apr; 52(4):984-9. PubMed ID: 8196191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
    Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
    Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine-699, a possible palmitoylation site of the thyrotropin receptor, is not crucial for cAMP or phosphoinositide signaling but is necessary for full surface expression.
    Kosugi S; Mori T
    Biochem Biophys Res Commun; 1996 Apr; 221(3):636-40. PubMed ID: 8630013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
    Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
    Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amino-terminal half of the cytoplasmic tail of the thyrotropin receptor is essential for full activities of receptor function.
    Kosugi S; Mori T
    Biochem Biophys Res Commun; 1994 Apr; 200(1):401-7. PubMed ID: 8166712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor.
    Claus M; Neumann S; Kleinau G; Krause G; Paschke R
    J Mol Med (Berl); 2006 Nov; 84(11):943-54. PubMed ID: 16955277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor.
    Kosugi S; Shenker A; Mori T
    FEBS Lett; 1994 Dec; 356(2-3):291-4. PubMed ID: 7805857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants for g protein activation and selectivity in the second intracellular loop of the thyrotropin receptor.
    Neumann S; Krause G; Claus M; Paschke R
    Endocrinology; 2005 Jan; 146(1):477-85. PubMed ID: 15498884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin stimulation of the lutropin/choriogonadotropin receptor: different sites mediate agonist activity and high affinity binding.
    Hidaka A; Ban T; Panesar NS; Minegishi T; Kohn LD; Tahara K
    Thyroid; 1994; 4(4):447-57. PubMed ID: 7711510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland].
    Shpakov AO; Shpakova EA; Tarasenko II; Derkach KV
    Tsitologiia; 2014; 56(7):526-35. PubMed ID: 25696997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
    Hidaka A; Okajima F; Ban T; Kosugi S; Kondo Y; Kohn LD
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1164-9. PubMed ID: 8077307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
    Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
    Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.